Research location
Auchenflower
Australia
Advertisement
Research activity in Auchenflower
AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 23 trials and 23 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Auchenflower
23 linked trials · page 1 of 1Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerNCT06890598 · 2025-03-27 · 1 site observation
RECRUITING
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801 · 2024-09-03 · 1 site observation
RECRUITING
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNCT06119581 · 2023-12-21 · 1 site observation
RECRUITING
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)NCT05934526 · 2023-12-28 · 1 site observation
COMPLETED
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).NCT05975905 · 2023-10-17 · 1 site observation
TERMINATED
De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 BlockadeNCT04675827 · 2022-01-17 · 1 site observation
TERMINATED
Portico Valve-in-Valve Retrospective RegistryNCT05002088 · 2021-10-21 · 1 site observation
COMPLETED
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast CancerNCT04739761 · 2021-06-22 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsNCT04482309 · 2020-08-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)NCT04338022 · 2020-06-12 · 1 site observation
TERMINATED
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409NCT02255656 · 2015-01-07 · 1 site observation
COMPLETED
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerNCT02032823 · 2014-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)NCT01945775 · 2013-10-14 · 1 site observation
COMPLETED
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant MesotheliomaNCT01843374 · 2013-05-17 · 1 site observation
ACTIVE_NOT_RECRUITING
CANVAS - CANagliflozin cardioVascular Assessment StudyNCT01032629 · 2009-12-09 · 1 site observation
COMPLETED
Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast CancerNCT00707707 · 2008-09-15 · 1 site observation
COMPLETED
Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaNCT00523042 · 2007-08-30 · 1 site observation
TERMINATED
A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.NCT00518011 · 2007-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)NCT00358436 · 2006-08-01 · 1 site observation
COMPLETED
Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)NCT00163358 · 2003-09-01 · 1 site observation
COMPLETED
Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 DiabetesNCT01467375 · 2001-01-08 · 1 site observation
COMPLETED
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast CancerNCT03763604 · 1 site observation
APPROVED_FOR_MARKETING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.